What is VeraDermics (NYS: MANE) worth?
$596.3Mlast known valuation
VeraDermics (NYS: MANE) last raised $150.0M in its Later Stage VC (Series C) (Oct 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 26 names
- ·Watchlist + deal alerts for VeraDermics (NYS: MANE)
Create free account
No card required
Funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Oct 2025 | Later Stage VC (Series C) | $150.0M | ▮ | ▮ |
How VeraDermics (NYS: MANE)'s valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For VeraDermics (NYS: MANE), too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is VeraDermics (NYS: MANE) worth?
- VeraDermics (NYS: MANE)'s last known valuation is $596.3M.
- How much has VeraDermics (NYS: MANE) raised?
- VeraDermics (NYS: MANE) has raised $518.6M in total funding across 1 recorded rounds.
- When did VeraDermics (NYS: MANE) last raise?
- VeraDermics (NYS: MANE) last raised in Oct 2025 (Later Stage VC (Series C)), raising $150.0M.